From: A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma
No.
Percent
Any failure
38
71.7
Locoregional failure only
10
18.9
Distant failure only
22
41.5
Locoregional plus distant
4
7.5
Toxicity
2
3.7